Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients?

Rossignol, PatrickAgarwal, Rajiv2025-03-112025-03-112021Rossignol P, Agarwal R. Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients? Nephrology Dialysis Transplantation. 2021;36(10):1771. doi:10.1093/ndt/gfab061https://hdl.handle.net/1805/46288en-USAttribution 4.0 InternationalCardiorenal syndromeChronic kidney diseaseHyperkalaemiaMineralocorticoid receptor antagonistRenin angiotensin aldosterone system inhibitorShould renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients?Article